The antimycobacterial MICs, SARs, and QSARs of some ethnobotanically selected phytocompounds

Forty ethnobotanically selected phytocompounds and four conventional TB treatment drugs were screened for their in vitro inhibitory activity against two strains of Mycobacterium tuberculosis. Compounds with better minimum inhibitory concentrations (MICs), than that of any of the four conventional TB treatment drugs, were identified as promising leads. The study identified six promising leads; three benzoquinones (114, 121, and 116), a flavone (141), an isoflavone (145), and an alkaloid (151). Structure–activity relationships (SARs) and quantitative structure–activity relationships (QSARs) were generated for the flavonoid and the benzoquinone series members. QSARs were used in the prediction of structural modifications necessary for activity improvement and in the prediction of activity of untested compounds.

[1]  J. Midiwo,et al.  6-Methoxycalpogonium Isoflavone A: A New Isoflavone from the Seed Pods of Millettia dura , 1997 .

[2]  M. Heydenreich,et al.  Four isoflavones from the stem bark of erythrina sacleuxii , 1998 .

[3]  K. Manchester.  Tuberculosis and leprosy in antiquity: an interpretation. , 1984, Medical History.

[4]  P HAUDUROY,et al.  MYCOBACTERIA: LABORATORY METHODS FOR TESTING DRUG SENSITIVITY AND RESISTANCE. , 1963, Bulletin of the World Health Organization.

[5]  A. Khomenko,et al.  Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes. , 1969, Bulletin of the World Health Organization.

[6]  J L McLaughlin,et al.  Bioactive compounds from the root of Myrsine africana. , 1989, Journal of natural products.

[7]  M. Muddassar,et al.  Molecular Docking and 3D QSAR Studies of Chk2 Inhibitors , 2009, Chemical biology & drug design.

[8]  N. H. Fischer,et al.  New perspectives on natural products in TB drug research. , 2005, Life sciences.

[9]  S. Seyedmousavi,et al.  Comparison of the In Vitro Activities of Newer Triazoles and Established Antifungal Agents against Trichophyton rubrum , 2015, Antimicrobial Agents and Chemotherapy.

[10]  H. H. Jaffé,et al.  A Reëxamination of the Hammett Equation. , 1953 .

[11]  K. Sterling.  MOLECULAR STRUCTURE OF THYROXINE IN RELATION TO ITS BINDING BY HUMAN SERUM ALBUMIN. , 1964, The Journal of clinical investigation.

[12]  A. Yenesew,et al.  Bioactive compounds from some Kenyan ethnomedicinal plants: Myrsinaceae, Polygonaceae and Psiadia punctulata , 2002, Phytochemistry Reviews.

[13]  W. Evans.  Trease and Evans' pharmacognosy, 14th edition , 1997 .

[14]  A. Nagendra,et al.  Incidence and Drug Susceptibility pattern of Mycobacterium tuberculosis in HIV infected Patien. , 2004, Medical journal, Armed Forces India.

[15]  H. Kubinyi.  QSAR : Hansch analysis and related approaches , 1993 .

[16]  P. Nassos,et al.  Broth microdilution testing of susceptibilities to 30 antimicrobial agents of Mycobacterium avium strains from patients with acquired immune deficiency syndrome , 1987, Antimicrobial Agents and Chemotherapy.

[17]  M. Meckes,et al.  Activity against multidrug‐resistant Mycobacterium tuberculosis in Mexican plants used to treat respiratory diseases , 2003, Phytotherapy research : PTR.

[18]  W. Roper,et al.  Plan to combat extensively drug-resistant tuberculosis: recommendations of the Federal Tuberculosis Task Force. , 2009, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[19]  A. J. Clark,et al.  The reaction between acetyl choline and muscle cells , 1926, The Journal of physiology.

[20]  M. Zenk,et al.  Occurrence and distribution of 7-methyljuglone and plumbagin in the droseraceae , 1969 .

[21]  H. Kubinyi.  QSAR: Hansch Analysis and Related Approaches: Kubinyi/QSAR , 1993 .

[22]  E. Nardell,et al.  Tuberculosis and HIV coinfection: current state of knowledge and research priorities. , 2007, The Journal of infectious diseases.

[23]  S. Rubbo,et al.  Mode of Action of isoNicotinic Hydrazide , 1955, Nature.

[24]  J. Pachón,et al.  Pharmacokinetic Interactions Between Efavirenz and Rifampicin in HIV-Infected Patients with Tuberculosis , 2002, Clinical pharmacokinetics.

[25]  K. Duncan.  Progress in TB drug development and what is still needed. , 2003, Tuberculosis.

[26]  C. Hansch,et al.  A NEW SUBSTITUENT CONSTANT, PI, DERIVED FROM PARTITION COEFFICIENTS , 1964 .

[27]  W. Burman.  Updated Guidelines on Managing Drug Interactions in the Treatment of HIV-Related Tuberculosis , 2014, Morbidity and Mortality Weekly Report.

[28]  M. Iseman,et al.  Ethambutol MICs and MBCs for Mycobacterium avium complex and Mycobacterium tuberculosis , 1986, Antimicrobial Agents and Chemotherapy.

[29]  Gordon M. Crippen,et al.  Atomic physicochemical parameters for three-dimensional-structure-directed quantitative structure-activity relationships. 2. Modeling dispersive and hydrophobic interactions , 1987, J. Chem. Inf. Comput. Sci..

[30]  Corwin Hansch,et al.  A survey of Hammett substituent constants and resonance and field parameters , 1991 .

[31]  L. Amzel,et al.  Tuberculosis drug targets. , 2002, Current drug targets.

[32]  C. Barry,et al.  Prospects for new antitubercular drugs. , 2004, Current opinion in microbiology.

[33]  L. Heifets.  MIC as a quantitative measurement of the susceptibility of Mycobacterium avium strains to seven antituberculosis drugs , 1988, Antimicrobial Agents and Chemotherapy.

[34]  R. W. Mwangi,et al.  Anti-feedant effects of surface accumulated flavonoids of Polygonum Senegalense , 1990 .

[35]  Mohammad Mustafizur Rahman,et al.  Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Laboratory Network: first round of proficiency testing. , 1997, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[36]  C. Hansch,et al.  SUBSTITUENT CONSTANTS FOR ALIPHATIC FUNCTIONS OBTAINED FROM PARTITION COEFFICIENTS. , 1965, Journal of medicinal chemistry.

[37]  J. Midiwo.  Distribution of anthraquinone pigments in Rumex species of Kenya , 1985 .

[38]  A. Laszlo,et al.  Conventional and radiometric drug susceptibility testing of Mycobacterium tuberculosis complex , 1983, Journal of clinical microbiology.

[39]  O. Rahn,et al.  Effect of Increase in Acidity on Antiseptic Efficiency , 1944 .

[40]  R. J. WULF,et al.  A CORRELATION OF VAN DER WAALS CONSTANTS WITH ANESTHETIC POTENCY , 1957, Anesthesiology.

[41]  J. Midiwo,et al.  FOUR ISOFLAVONES FROM SEED PODS OF MILLETTIA DURA , 1996 .

[42]  R. Rosenfeld.  Nature , 2009, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[43]  A. Vibhagool,et al.  Efavirenz 600 mg/day versus efavirenz 800 mg/day in HIV-infected patients with tuberculosis receiving rifampicin: 48 weeks results , 2006, AIDS.

[44]  S. Siddiqi,et al.  Interlaboratory drug susceptibility testing of Mycobacterium tuberculosis by a radiometric procedure and two conventional methods , 1985, Journal of clinical microbiology.

[45]  Barry L. Levinson,et al.  Quantitative Drug Design: A Critical Introduction , 1979, The Yale Journal of Biology and Medicine.

[46]  J. Kokwaro.  Medicinal plants of East Africa , 1976 .

[47]  D. Hoekman.  Exploring QSAR Fundamentals and Applications in Chemistry and Biology, Volume 1. Hydrophobic, Electronic and Steric Constants, Volume 2 J. Am. Chem. Soc. 1995, 117, 9782 , 1996 .

[48]  L. Schanker.  On the mechanism of absorption of drugs from the gastrointestinal tract. , 1960, Journal of medicinal and pharmaceutical chemistry.

[49]  Bernard Testa,et al.  QSAR: Hansch analysis and related approaches , 1995 .

[50]  M. Heydenreich,et al.  Two isoflavanones from the stem bark of Erythrina sacleuxii. , 2000, Phytochemistry.

[51]  L. M. Arot.  Phytochemical Analysis Of Myrsine Africana Land Maesa Lanceolata Forsk And Structure Activity Relationship Studies Of 2,5-dihydroxyalkylbenzoquinones , 1994 .

[52]  W. Paton,et al.  A theory of drug action based on the rate of drug-receptor combination , 1961, Proceedings of the Royal Society of London. Series B. Biological Sciences.

[53]  H. Darmani.  Todar's Online Textbook of Bacteriology , 2006 .

[54]  J. Gerberding,et al.  Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs--worldwide, 2000-2004. , 2006, MMWR. Morbidity and mortality weekly report.

[55]  J. Midiwo,et al.  Flavones and phenylpropenoids in the surface exudate of Psiadia punctulata. , 2001, Phytochemistry.

[56]  A. Tomlinson,et al.  The influence of chemical constitution on antibacterial activity. VIII. 2-Mercaptopyridine-N-oxide, and some general observations on metalbinding agents. , 1956, British journal of experimental pathology.

[57]  M. Heydenreich,et al.  Three isoflav-3-enes and a 2-arylbenzofuran from the root bark of Erythrina burttii. , 2002, Phytochemistry.

[58]  C. Wermuth,et al.  Comprar The Practice of Medicinal Chemistry, 3rd Edition | Camille G. Wermuth | 9780123741943 | Academic Press , 2009 .

[59]  Corwin Hansch,et al.  Comprehensive medicinal chemistry : the rational design, mechanistic study & therapeutic application of chemical compounds , 1990 .

[60]  J. Stenlake,et al.  The possible role of conformational isomerism in the biological actions of acetylcholine , 1967, The Journal of pharmacy and pharmacology.

[61]  M. Addy.  WESTERN AFRICA NETWORK OF NATURAL PRODUCTS RESEARCH SCIENTISTS (WANNPRES), FIRST SCIENTIFIC MEETING AUGUST 15 -20, 2004. ACCRA, GHANA : A REPORT , 2005 .

[62]  R. Wallace,,et al.  Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes , 2011 .

[63]  L. Kier.  Molecular orbital calculations of the preferred conformations of histamine and a theory on its dual activity. , 1968, Journal of medicinal chemistry.

[64]  L. Kaplan,et al.  Clinical Chemistry: Theory, Analysis, and Correlation , 1984 .

[65]  M. Borgdorff,et al.  Altitude: a determinant for tuberculosis in Kenya? , 1999, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[66]  B. Belleau.  A MOLECULAR THEORY OF DRUG ACTION BASED ON INDUCED CONFORMATIONAL PERTURBATIONS OF RECEPTORS. , 1964, Journal of medicinal chemistry.

[67]  S. Cho,et al.  Pharmacophore Identification and Validation Study of CK2 Inhibitors Using CoMFA/CoMSIA , 2009, Chemical biology & drug design.

[68]  R. W. Mwangi,et al.  Insect Antifeedant, Growth-Inhibiting and Larvicidal Compounds from Rapanea melanphloes (Myrsinaceae) , 1995 .

[69]  大野秀明.  Relationship between Rifampin MICs for and rpoB Mutations of Mycobacterium tuberculosis Strains Isolated in Japan , 1997 .

[70]  P. Yogeeswari,et al.  Synthesis, in vitro and in vivo antimycobacterial activities of diclofenac acid hydrazones and amides. , 2006, Bioorganic & medicinal chemistry.

[71]  H. Aramaki,et al.  Rifampicin resistance and mutation of the rpoB gene in Mycobacterium tuberculosis. , 1996, FEMS microbiology letters.

[72]  B. Brodie,et al.  Absorption of drugs from the stomach. II. The human. , 1957, The Journal of pharmacology and experimental therapeutics.